| 30-day survival | 90-day survival | Overall survival | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
P | RR | 95% CL for RR | P | RR | 95% CL for RR | P | RR | 95% CL for RR | ||||
Lower | Upper | Lower | Upper | Lower | Upper | |||||||
Age | 0.272 | 0.975 | 0.932 | 1.020 | 0.768 | 0.995 | 0.962 | 1.029 | 0.388 | 1.009 | 0.989 | 1.029 |
Sex | 0.248 | 0.455 | 0.120 | 1.731 | 0.262 | 0.623 | 0.272 | 1.425 | 0.431 | 0.837 | 0.537 | 1.304 |
Race (reference: Black) | 0.724 | Â | Â | Â | 0.858 | Â | Â | Â | 0.949 | Â | Â | Â |
 Hispanic | 0.287 | 0.383 | 0.065 | 2.240 | 0.684 | 0.792 | 0.259 | 2.428 | 0.626 | 1.180 | 0.607 | 2.295 |
 Other | 0.697 | 1.532 | 0.178 | 13.152 | 0.485 | 0.484 | 0.063 | 3.704 | 0.809 | 0.911 | 0.430 | 1.933 |
 Non-Hispanic white | 0.972 | 0.000 | 0.000 | undefined | 0.654 | 0.696 | 0.143 | 3.385 | 0.808 | 1.129 | 0.422 | 3.021 |
Cancer type (liquida vs. solid) | 0.955 | 0.000 | 0.000 | undefined | 0.018* | 0.042 | 0.003 | 0.580 | 0.016* | 0.218 | 0.063 | 0.752 |
Cancer stage (reference: 0) | 0.941 | Â | Â | Â | 0.938 | Â | Â | Â | 0.004* | Â | Â | Â |
 I | >0.999 | 1.154 | 0.000 |  | 0.996 | 0.000 | 0.000 |  | 0.963 | 0.000 | 0.000 | undefined |
 II | 0.989 | 0.000 | 0.000 |  | 0.984 | 0.000 | 0.000 |  | 0.015 | 0.085 | 0.012 | 0.618 |
 III | 0.377 | 2.364 | 0.350 | 15.969 | 0.980 | 1.022 | 0.189 | 5.512 | 0.035 | 0.213 | 0.050 | 0.900 |
 IV | 0.961 | 0.000 | 0.000 | undefined | 0.375 | 0.501 | 0.109 | 2.306 | 0.013 | 0.363 | 0.163 | 0.809 |
ECOG PS (reference: 0) | 0.136 | Â | Â | Â | 0.084 | Â | Â | Â | 0.020* | Â | Â | Â |
 1 | 0.972 | 0.000 | 0.000 |  | 0.979 | 0.000 | 0.000 |  | 0.010 | 0.084 | 0.013 | 0.553 |
 2 | 0.013 | 0.028 | 0.002 | 0.473 | 0.093 | 0.145 | 0.015 | 1.384 | 0.190 | 0.416 | 0.112 | 1.543 |
 3 | 0.079 | 0.099 | 0.008 | 1.308 | 0.311 | 0.328 | 0.038 | 2.836 | 0.192 | 0.427 | 0.119 | 1.536 |
 4 | 0.135 | 0.106 | 0.006 | 2.004 | 0.824 | 0.773 | 0.081 | 7.419 | 0.910 | 1.085 | 0.263 | 4.475 |
Charlson comorbidity index (age unadjusted) | 0.025* | 0.518 | 0.291 | 0.922 | 0.017* | 0.593 | 0.386 | 0.911 | 0.041* | 0.766 | 0.592 | 0.990 |
Tachycardia (>100 beats/min) | 0.714 | 0.718 | 0.122 | 4.235 | 0.635 | 0.761 | 0.246 | 2.356 | 0.804 | 1.081 | 0.582 | 2.008 |
Hypotension (systolic <100Â mmHg) | 0.995 | 103681.952 | 0.000 | Â | 0.993 | 407878.592 | 0.000 | Â | 0.710 | 1.465 | 0.195 | 10.983 |
Tachypnea (>20 breaths/min) | 0.058 | 0.123 | 0.014 | 1.075 | 0.167 | 0.314 | 0.061 | 1.626 | 0.594 | 0.723 | 0.220 | 2.380 |
Hypoxemia (oxygen saturation <93%) | 0.030* | 0.096 | 0.011 | 0.800 | 0.207 | 0.385 | 0.088 | 1.694 | 0.978 | 0.987 | 0.388 | 2.510 |
Location of incidental PE (reference: subsegmental) | 0.009* | Â | Â | Â | 0.083 | Â | Â | Â | 0.170 | Â | Â | Â |
 Saddle | 0.004* | 33.513 | 3.142 | 357.404 | 0.023 | 6.185 | 1.282 | 29.828 | 0.287 | 1.742 | 0.627 | 4.841 |
 Main/lobar pulmonary artery | 0.316 | 2.992 | 0.351 | 25.472 | 0.248 | 2.199 | 0.577 | 8.382 | 0.688 | 1.144 | 0.595 | 2.199 |
 Segmental | 0.713 | 1.492 | 0.177 | 12.549 | 0.570 | 1.425 | 0.420 | 4.826 | 0.269 | 0.736 | 0.428 | 1.267 |